Clinical trial
Statins in Proteinuric Nephropathies
NCT00199927 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00199927 |
|---|---|
| Title | Statins in Proteinuric Nephropathies |
| Official title | A Prospective, Randomized, Multicenter Trial Testing the Antiproteinuric Effect of Statins Added to Combined ACE-inhibitor and Angiotensin Receptor Antagonist Therapy in Proteinuric, Chronic Nephropathies |
| Acronym | ESPLANADE |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Nephropathy, Proteinuria, Hypertension |
| Intervention type | Drug |
| Interventions | Fluvastatin, standard therapy |
| Enrollment | 217 |
| Start date | Mar 1, 2003 |
| Primary completion | Dec 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 28, 2010 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: